NCT00169247View on ClinicalTrials.gov

Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation

PHASE2CompletedINTERVENTIONAL
Enrollment

156

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

April 30, 2011

Conditions
Larynx CancerHypopharynx Cancer
Interventions
DRUG

cetuximab

DRUG

Cisplatin

PROCEDURE

Radiotherapy 70 Gy, 35 fractions

Trial Locations (3)

37044

CHU de Tours, Tours

44805

Centre René Gauducheau, Nantes

59020

Centre Oscar Lambret, Lille

All Listed Sponsors
collaborator

Tumor Study Group Head and Neck

OTHER

lead

Groupe Oncologie Radiotherapie Tete et Cou

OTHER

NCT00169247 - Radiotherapy With Cisplatin Versus Radiotherapy With Cetuximab After Induction Chemotherapy for Larynx Preservation | Biotech Hunter | Biotech Hunter